# NHS Challenges Palantir Over Federated Data Platform Performance Claims NHS England seeks to regulate public benefit claims regarding Palantir's controversial health data software. - **Source:** [www.theregister.com - Articles](https://brifing.si/source/2c34ea50-d341-4a10-925d-12c012a9ad10) - **Published:** 2026-11-06 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/3d02df30-549e-424e-af14-7d7472ab3faa ## Regulatory Oversight of Claims NHS England CEO Sir Jim Mackey intends to mandate that Palantir clear all future public benefit claims with his team. This move follows concerns raised by MP Ben Coleman regarding Palantir UK senior vice president Tom Watson, who has publicly attributed hospital performance improvements directly to the company's Federated Data Platform software. ## Contractual Enforcement Challenges Despite the directive, Mackey admitted that enforcing such communication requirements might be legally difficult under the existing agreement. The £330 million contract, awarded in November 2023, lacks clear provisions to restrict the vendor's marketing statements. Consequently, the NHS faces a significant hurdle in controlling the narrative surrounding the platform's actual operational impact. ## Disputed Efficiency Metrics NHS England previously claimed 137 trusts reported benefits, citing an additional 111,589 procedures performed using the platform. However, Freedom of Information requests revealed that nearly one-third of participating trusts actually performed fewer procedures after implementation. These discrepancies have fueled ongoing scrutiny regarding the validity of the data used to justify the contract. ## Regulatory Intervention and Caveats The Office for Statistics Regulation intervened after campaign group Foxglove questioned the figures presented in Parliament. NHS England subsequently added a caveat to its website, acknowledging that it cannot draw definitive conclusions about cause and effect. The regulator noted that other variables, such as staffing levels and industrial action, remain uncontrolled in current analyses. ## Palantir's Public Defense Tom Watson, former deputy leader of the Labour Party, has actively sought to rebut criticism by highlighting positive reports from specific hospitals. While acknowledging that the platform cannot be solely credited for every procedure, Watson argues that hospital feedback remains a valid indicator of success, despite the lack of rigorous, controlled academic studies. ## Independent Evaluation Timeline In February 2026, NHS England commissioned Imperial College Projects to conduct an independent evaluation of the Federated Data Platform. This assessment aims to provide a more objective view of the software's utility. However, the final findings are not expected to be released until after the government decides whether to extend the current contract. ## Contractual Lifecycle Context The current agreement with the Palantir-led consortium is scheduled to conclude in March 2027. The timing of the independent evaluation is critical, as it will likely influence ministerial decisions regarding a potential extension. Stakeholders are closely watching whether the software can demonstrate tangible, statistically significant improvements before the current funding cycle expires. ## Broader Implications for Procurement This dispute highlights the complexities of integrating private sector technology into public health infrastructure. The tension between vendor marketing and regulatory caution underscores the need for transparent performance metrics. As the NHS navigates these data-driven challenges, the outcome will likely set a precedent for how future large-scale digital health contracts are managed. ## Sources covering this story - https://www.theregister.com/public-sector/2026/11/06/nhs-wants-a-second-opinion-on-palantirs-glowing-self-assessments/5307809 — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._